Ildong Pharmaceutical Expands Dyslipidemia Drug "Droptop" into Three Additional ASEAN Countries

Establishing Partnership with Kalbe Group in Eight Southeast Asian Countries

Ildong Pharmaceutical announced on April 14 that it has signed an additional agreement with its Indonesian partner Kalbe Farma to expand the supply territory of its product "Droptop" in order to increase its presence in Southeast Asia.

Droptop is a combination drug for the treatment of dyslipidemia, composed of rosuvastatin, a statin-class medication that inhibits cholesterol synthesis in the body, and ezetimibe, an ingredient that reduces cholesterol absorption in the body.

Ildong Pharmaceutical has signed a contract with Kalbe International, the distribution subsidiary of Kalbe Farma, to expand the supply scope of Droptop to three additional ASEAN countries. As a result, Ildong Pharmaceutical has established a cooperative relationship with Kalbe Group in a total of eight Southeast Asian countries for the dyslipidemia therapeutics market, including Indonesia and its neighboring countries, which were previously in the supply territory.

Ildong Pharmaceutical entered into a partnership agreement with Kalbe Farma, the leading pharmaceutical company in Indonesia, in 2020 regarding the supply of Droptop, and after obtaining regulatory approval and completing the launch process, has been exporting the product since 2023. Droptop is sold locally under the brand name "Rozet" and has achieved an average annual growth rate of about 130% over the three years since its launch, securing the number one market share in the Indonesian combination drug segment for dyslipidemia treatment.

Ildong Pharmaceutical plans to accelerate the market penetration of Droptop by sequentially pursuing product approvals and launch procedures in the contracted countries, based on its partnership with Kalbe Group, while also implementing locally tailored marketing and distribution strategies.

A representative from Ildong Pharmaceutical stated, "With this agreement, Droptop can now enter most of the ASEAN member states that serve as the economic hub of Southeast Asia," and added, "We will continue to expand both our market coverage and product offerings together with Kalbe Group."

This content was produced with the assistance of AI translation services.